News feed on Vet Dx
Friday, September 24, 2021
September 24, 2021 at 08:05PM CUVITRU
Product approval information is indicated for replacement therapy for primary humoral immunodeficiency (PI) in adult and pediatric patients two years of age and older.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2WJ3mKO
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment